IL6 and pancreatic neoplasm: By binding to CXCR4/CXCR7 on the SCs, SCs downregulate the expression of multiple pain associated targets to attenuate pain perception, while IL-6 secreted by activated SCs suppresses pain signaling, collectively delaying pancreatic cancer diagnosis (198, 201).